FDA continues battle against large animal antiparasitic resistanceJanuary 2, 2020With 2020 underway, the U.S. Food and Drug Administration (FDA) says it is continuing its ongoing effort to address issues related to antiparasitic resistance in livestock and horses across the country.
Education Center - SponsoredA New Way Forward in Canine Osteoarthritis: Targeting Pain and Inflammation at Its Sourceby • Exubrion Therapeutics The traditional approach to canine osteoarthritis (OA) has largely focused on treatments such as NSAIDs, joint supplements, stem cell, PRP, and anti-nerve growth factor (anti-NGF) injections. This raises a critical question: What if we could do more than manage symptoms? What if we could target the inflammation driving the disease?
